Statement of Comprehensive Income of the Merck Group

XLS

€ million

Jan.–Sep.
2011

Jan.–Sep.
2010

Profit after tax

490.0

596.0

Available-for-sale financial assets

 

 

Fair value adjustments

26.1

–2.0

Reclassification to income statement

–27.0

Deferred taxes

1.4

0.3

Changes recognized in equity

0.5

–1.7

Derivative financial instruments

 

 

Fair value adjustments

–32.6

–42.3

Reclassification to income statement

–6.8

–14.3

Deferred taxes

7.6

10.2

Changes recognized in equity

–31.8

–46.4

Actuarial gains and losses from defined
benefit obligations and similar obligations

 

 

Changes in actuarial gains and losses

–5.6

–93.6

Deferred taxes

1.3

18.3

Changes recognized in equity

–4.3

–75.3

Exchange differences on translating foreign operations

 

 

Changes taken directly to equity

–75.1

778.0

Reclassification to income statement

3.5

-

Changes recognized in equity

–71.6

778.0

Gains/losses recognized immediately in equity

–107.2

654.6

Comprehensive income

382.8

1,250.6

of which attributable to shareholders of the parent company

377.3

1,235.2

of which attributable to non-controlling interest

5.5

15.4